Edwin Alexander Alvarez

MD

Gynecologic cancer surgeon

About me

Dr. Edwin Alexander Alvarez is a gynecologic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. He focuses on the surgical and medical treatment of ovarian cancer, cervical cancer, endometrial cancer and other cancers of the female reproductive system. He performs traditional, complicated and minimally invasive gynecologic surgeries.

UCSF recruited Alvarez to serve as director of clinical trials for the Division of Gynecologic Oncology. He is involved with NRG Oncology, a cooperative research group for cancer clinical trials sponsored by the National Cancer Institute. Before coming to UCSF, he directed chemotherapy services for gynecologic cancers at the University of California, Davis.

In addition to caring for patients, Alvarez has a strong commitment to teaching medical students, residents and fellows.

  • Education

    UC San Diego School of Medicine, 2000

  • Residencies

    LAC-USC Medical Center, Obstetrics and Gynecology, 2004

  • Fellowships

    University of Miami School of Medicine, Gynecologic Oncology, 2007

  • Academic Title

    Associate Professor

  • Languages

    Spanish

Gynecologic Surgical Oncology Clinic

Bakar Precision Cancer Medicine Building

1825 Fourth St., Sixth Floor
San Francisco, CA 94158

My reviews

4.9

Overall Experience
161 Reviews
I am being treated for stage 4 uterine cancer. Dr. Alvarez is an outstanding compassionate caring knowledgeable doctor. I would highly recommend him.
Explained things in a way that was easy to understand
161 Reviews
Did the doctor pay attention to your concerns
161 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
160 Reviews
Knew the important information about your medical history
159 Reviews
The provider showed respect for what you had to say
160 Reviews
The provider spent enough time with me
161 Reviews
Decorative Caduceus

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance ...

Defined as time from randomisation to first progression by investigator assessment using modified RECIST 1.1 or death (by any cause in the absence of progression)

Recruiting

Decorative Caduceus

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant O...

Recruiting

Share